MicroPort Total Knee System
Suzhou Microport Orthorecon Co., Ltd. · Decision date Oct 29, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision on 2026-10-29 for K263065, the MicroPort Total Knee System, submitted by Suzhou Microport Orthorecon Co., Ltd. The filing was received 09/01/2026 as a Traditional 510(k), reviewed by the Orthopedic panel, and not reviewed by a third party. The device falls under product code JWH, with HRY listed as a subsequent product code, and regulation number 888.3560.
SESE in a 510(k) means the submission was cleared as substantially equivalent to a legally marketed predicate; it is not a PMA approval. The source records do not identify the predicate device, the specific components or design changes at issue, or any clinical data, so the scope of what was cleared beyond the device name and classification remains unknown. No summary content was available in the retrieved excerpts.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Oct 29, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K263065
- Regulatory pathway
- 510(k) premarket notification
- Product code
- JWH
- Decision code
- SESE
- Decision date
- Oct 29, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer.
- Product code
- JWH
- FDA device class
- 2
FDA decision timeline
K263065 received
Application receipt date recorded by FDA.
K263065 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code JWH
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
GMK ExtensionK262057 | Medacta International SA | 510(k) clearance | Sep 15, 2026 | FDA |
GSPE SpacerK260063 | The General Hospital Corporation, d/b/a Massachusetts | 510(k) clearance | Sep 11, 2026 | FDA |
| Suzhou Microport Orthorecon Co., Ltd. | 510(k) clearance | Sep 10, 2026 | FDA | |
| B-One Ortho, Corp. | 510(k) clearance | Sep 8, 2026 | FDA | |
ATTUNE Revision Knee SystemK262130 | Depuy Orthopaedics, Inc. | 510(k) clearance | Sep 4, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Suzhou Microport Orthorecon Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Suzhou
Sources and methodology
- Original FDA record: K263065
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



